Group structure
21 companies in 11 countries
Loading…
21 companies in 11 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1–25 of 352
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Allerfre, tabletten 10 mgTablet | Loratadine | Netherlands | Authorised | 2002 |
| BENAGOL TOSSE SECCASciroppo | Plantago lanceolata foglie, estratto secco | Italy | Authorised | |
| BONJELA GEL0.01% w/w + 8.714% W/W · GEL | Cetalkonium, Choline salicylate | Singapore | Authorised | 1990 |
| CARDIPRIN 100 TABLET 100 mg100 mg · Tablet | Acetylsalicylic acid | Singapore | Authorised | 1991 |
| CEPACOL CHILDREN'S FRUITY STRAWBERRY0.6 mg + 1.2 mg · Lozenge | Amylmetacresol, Dichlorobenzyl alcohol | Canada | Marketed | 2013 |
| CEPACOL INSTASOOTHE SORE THROAT + PAIN RELIEF2 mg · Lozenge | Hexylresorcinol | Canada | Authorised | |
| CEPACOL INSTASOOTHE SORE THROAT RELIEF + SOOTHING COMFORT2.4 mg · Lozenge | Hexylresorcinol | Canada | Marketed | |
| CEPACOL SENSATIONS0.6 mg + 1.2 mg · Lozenge | Amylmetacresol, Dichlorobenzyl alcohol | Canada | Marketed | 2012 |
| CEPACOL SENSATIONS COOL MINT0.6 mg + 1.2 mg + 8 mg · Lozenge | Amylmetacresol, Dichlorobenzyl alcohol, Menthol | Canada | Authorised | |
| CEPACOL SENSATIONS SORE THROAT & BLOCKED NOSE0.6 mg + 1.2 mg + 8 mg · Lozenge | Amylmetacresol, Dichlorobenzyl alcohol, Levomenthol | Canada | Marketed | 2012 |
| CEPACOL SENSATIONS SORE THROAT & COUGH0.6 mg + 1.2 mg + 8 mg · Lozenge | Amylmetacresol, Dichlorobenzyl alcohol, Menthol | Canada | Marketed | 2012 |
| Citrosan, poeder in sachetPoeder voor oraal gebruik | Ascorbic acid, Paracetamol | Netherlands | Authorised | 1971 |
| DETTOL4.8 % / w/w · Solution | Chloroxylenol | Canada | Marketed | 1938 |
| Dettol Med Benzalkoniumchloride 2 mg/g huidspray, oplossing voor cutaan gebruikHuidspray, oplossing | Benzalkonium | Netherlands | Authorised | 2010 |
| Dettol Med Chloorxylenol 48 mg/g, concentraat voor oplossing voor cutaan gebruikConcentraat voor oplossing voor cutaan gebruik | Chloroxylenol | Netherlands | Authorised | 2009 |
| Gaviscon 250 mg aardbei, kauwtablettenKauwtablet | Carbonate, Natriumalginaat, Cloreto | Netherlands | Authorised | 2005 |
| GAVISCON ADVANCE-PEPPERMINT FLAVOUR SUSPENSION200 mg/10 ml + 1000 mg/10 ml · Suspension | Bicarbonate, Alginate | Singapore | Authorised | 2004 |
| Gaviscon anijs, suspensieSuspensie voor oraal gebruik | Natriumalginaat, Cloreto | Netherlands | Authorised | 1981 |
| GAVISCON COMPRIMIDOS MASTICABLES SABOR FRESA250,000 mg + 133,50 mg + 80,000 mg · Comprimido masticable | Alginate, Bicarbonate, Carbonate | Spain | Marketed | 2015 |
| GAVISCON COMPRIMIDOS MASTICABLES SABOR FRESA250 mg + 133,5 mg + 80 mg · Comprimido masticable | Alginate, Bicarbonate, Carbonate | Spain | Marketed | 2025 |
| GAVISCON COMPRIMIDOS MASTICABLES SABOR MENTA250,00 mg + 80,00 mg + 133,50 mg · Comprimido masticable | Alginate, Carbonate, Bicarbonate | Spain | Marketed | 2011 |
| GAVISCON DOUBLE ACTION LIQUID, SUSPENSION325mg/10ml + 500mg/10ml + 213mg/10ml · Suspension | Carbonate, Alginate, Bicarbonate | Singapore | Authorised | 2011 |
| GAVISCON DOUBLE ACTION TABLETS187.5mg + 250mg + 106.5mg · Tablet, chewable | Carbonate, Alginate, Bicarbonate | Singapore | Authorised | 2012 |
| Gaviscon Duo Bosvruchten, kauwtablettenKauwtablet | Carbonate, Natriumalginaat, Cloreto | Netherlands | Authorised | 2023 |
| Gaviscon Duo Bosvruchtensmaak 250 mg/106,5 mg /187,5 mg, kauwtablettenKauwtablet | Carbonate, Natriumalginaat, Cloreto | Netherlands | Authorised | 2024 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 138 | 78 | 60 | CompaniesAll medicines |
| Netherlands | 53 | 53 | 0 | CompaniesAll medicines |
| Spain | 49 | 39 | 10 | CompaniesAll medicines |
| Brazil | 33 | 11 | 22 | CompaniesAll medicines |
| Croatia | 29 | 29 | 0 | CompaniesAll medicines |
| Singapore | 27 | 27 | 0 | CompaniesAll medicines |
| Saudi Arabia | 22 | 22 | 0 | CompaniesAll medicines |
| Italy | 1 | 1 | 0 | CompaniesAll medicines |
Also in the registers of Colombia, France, Malaysia, Serbia, Sweden, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licence: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, https://dados.anvisa.gov.br/dados/CONSULTAS/EMPRESA_FISCALIZACAO_PRODUTO/TA_CONSULTA_CBPF_MEDICAMENTO_DETALHE.CSV; source modified Fri, 15 May 2026 07:52:35 GMT; acquired 2026-10-18T08:23:43.211112+00:00; original factual values retained, no endorsement.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Agência Nacional de Vigilância Sanitária (Anvisa), DATAVISA open-data register; source modification 2026-10-07, acquired 2026-10-07 UTC.
Licence: Brazil federal open-data reuse, Decreto 8777/2016, consolidated article 4 as amended by Decreto 9903/2019
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Report an error or request removalCorrections from the company itself are welcome.
Keep Reckitt’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callFuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
GLEIF; exact source URL and retrieval date; no endorsement.
Licence: CC0
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
AIFA, https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv, HTTP Last-Modified Mon, 26 Oct 2026 00:02:13 GMT, acquired 2026-10-26T09:43:33.749886+00:00; factual native values retained; exact row correspondence and projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Läkemedelsverket, Sweden, Förvaringstemperatur och hållbarhet, source extract 2026-10-20, acquired 2026-10-20T20:46:08.868635+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Contains information from ACRA Information on Corporate Entities, accessed on 8 October 2026 through Data.gov.sg, under Singapore Open Data Licence version 1.0: https://data.gov.sg/open-data-licence. Structured selection and normalisation by Prognia; original UEN, field and retrieval date retained.
Licence: Singapore Open Data Licence
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Well-known pharmaceutical groups, each with all its companies.